Comments on: A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease https://scdstudies.com/a-phase-1b-sequential-open-label-dose-ranging-study-of-safety-pharmacokinetics-and-preliminary-activity-of-benserazide-in-subjects-with-beta-thalassemia-intermedia/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-1b-sequential-open-label-dose-ranging-study-of-safety-pharmacokinetics-and-preliminary-activity-of-benserazide-in-subjects-with-beta-thalassemia-intermedia Sun, 23 Jun 2024 12:22:54 +0000 hourly 1 https://wordpress.org/?v=6.7.1